SCHEMBL7834254

SCHEMBL7834254

CC(C)c1cn(C(=O)OC(C)(C)C)c(=O)[nH]c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 2/20 0.34
▸ THRA P10827 1/20 0.34
▸ GRIA1 P42261 4/20 0.34
▸ GRIA2 P42262 4/20 0.34
▸ GRIA4 P48058 4/20 0.34
▸ GRIK5 Q16478 4/20 0.34
▸ HTT P42858 3/20 0.34
▸ BUB1 O43683 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TK1 P04183 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ USP1 O94782 1/20 0.32
▸ DDB1 Q16531 1/20 0.32
▸ CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16653120 0.80 TK1 (0.43) BUB1TK1MAPK1TYMP
SCHEMBL10953281 0.79 GRIA1 (0.36) GRIA1GRIA2GRIA4GRIK5HTT
SCHEMBL8235112 0.79 SQOR (0.49) GRIA1GRIA2GRIA4GRIK5BUB1
SCHEMBL5334520 0.79 TYMP (0.45) THRBGRIA1GRIA2GRIA4GRIK5
SCHEMBL15616807 0.79 LMNA (0.46) GRIA1GRIA2GRIA4GRIK5BUB1
SCHEMBL4156346 0.79 TYMP (0.45) THRBGRIA1GRIA2GRIA4GRIK5
SCHEMBL7821308 0.77 BUB1 (0.34) THRBBUB1BCHETK1L3MBTL1
SCHEMBL20438154 0.76 BUB1 (0.38) THRBBUB1BCHEL3MBTL1MAPT
SCHEMBL20445101 0.76 BUB1 (0.38) THRBBUB1BCHEL3MBTL1MAPT
SCHEMBL7830622 0.73 PIK3R1 (0.44) BUB1BCHENPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 — — EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 — — US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 — — EP disclosed
Send feedback